NeuroSense receives US patent for Alzheimer's treatment through 2043
Go back to NeuroSense receives US patent for Alzheimer's treatment through 2043| (NASDAQ: NRSN) | Delayed: 3.66 +0.08 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $ | |||
| Open | $3.61 | 52 Week Low | $ | |||
| Day High | $3.85 | P/E | N/A | |||
| Day Low | $3.61 | EPS | $ | |||
| Volume | 15,607 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 7 | |||||



